NIIN Output Data
NIIN:
NSN:
Item Name:
ESTRADIOL TRANSDERMAL SYSTEM
Definition:
Reference/Part Number
Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
---|---|---|---|---|---|---|---|---|
VIVELLE-DOT | 04520 | A | 5 | 1 | 4 | ZZ | ||
NDC00078-0345-45 | 04520 | A | 3 | 2 | 4 | ZZ | ||
05-1552 | 89875 | A | 5 | 1 | 4 | ZZ |
CAGE Information
Code | Company |
---|---|
04520 | NOVARTIS PHARMACEUTICALS CORPORATION |
89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
MRC | Requirements Statement | Clear Text Reply |
---|---|---|
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ESTRADIOL TRANSDERMAL SYSTEM 0.075MG/24 HOURS PATCH 8EA 3S |
AJUC | AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 681604 |
CSLZ | USUAL DOSE | 0.075MG RELEASE PER 24 HOURS |
CYMT | OVERALL STRENGTH IN SYSTEM | 1.17MG ESTRADIOL USP ACTIVE INGREDIENT |
FEAT | SPECIAL FEATURES | USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C |
CYMU | SYSTEM SIZE | 7.5 SQUARE CENTIMETERS |
CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |